Provided by Tiger Trade Technology Pte. Ltd.

HORIZON KINETICS MEDICAL ETF

35.29
+0.33190.95%
Post-market: 35.300.0109+0.03%16:10 EDT
Volume:227
Turnover:8K
Market Cap:16.58M
PE:- -
High:35.30
Open:35.30
Low:35.29
Close:34.96
52wk High:37.90
52wk Low:28.87
Shares:469.95K
Float Shares:469.95K
Volume Ratio:0.09
T/O Rate:0.05%
Dividend:0.41
Dividend Rate:1.16%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Dow Jones Top Company Headlines at 11 am ET: Microsoft Sets Limits for AI Models as Altman Details Control Risks | Dell's ...

Dow Jones
·
Yesterday

CRO Sector Surges Strongly as Multiple Listed Companies Share Latest Business Updates

Deep News
·
Yesterday

Eli Lilly Announces R$ 0.2 Per Unit Dividend for 3Q 2026 BDRs

Reuters
·
Yesterday

Sector Update: Healthcare Stocks Rise Premarket Monday

MT Newswires Live
·
Yesterday

Hong Kong Stocks Recover as WCLC Conference Sparks Biotech Rally, While US AI Slowdown Calls Raise Questions

Stock News
·
Yesterday

U.S. Stocks on the MOVE-US Energy Stocks, Baldwin, Johnson & Johnson

Reuters
·
Yesterday

J&J - Jnj Reports Rybrevant Plus Chemotherapy Extends Pfs2 by 10.8 Months in Nsclc

THOMSON REUTERS
·
Yesterday

Johnson & Johnson’s Rybrevant® (Amivantamab-Vmjw) Plus Chemotherapy Delivers Longest Reported Median Overall Survival in Egfr Exon 20 Insertion Mutation-Positive Lung Cancer

THOMSON REUTERS
·
Yesterday

J&J - Jnj Reports no New Safety Signals for Rybrevant Plus Chemotherapy in Nsclc Study

THOMSON REUTERS
·
Yesterday

Healthcare Priorities Over Next Five Years to Target Three Population Groups

Deep News
·
Yesterday

Potential Buyer Emerges for Johnson & Johnson's Orthopedics Unit

Deep News
·
Yesterday

Market Consolidation with Low Volume: Innovative Drugs Surge Against the Trend, Banking Index Hits New Annual High, Optical Module Leaders Retreat While Capital Seeks Opportunities in High-Optical ETFs

Deep News
·
Yesterday

Immunocore achieves target patient enrollment in TEBE-AM clinical trial

TIPRANKS
·
Yesterday

ETF Market Recap: Short-Term Opportunities Emerge in Previously Corrected Innovative Drug and CXO Sectors Amidst Soft Broader Market Momentum

Deep News
·
Yesterday

Hengrui's Novel Factor XI Monoclonal Antibody Wins NMPA Acceptance for VTE Prevention in Elective Knee Replacement Surgery

Deep News
·
Yesterday

CMS Secures Clinical Trial Green Light for Innovative Lupus Treatment Candidate

Stock News
·
Yesterday

Johnson & Johnson reports PAPILLON study meets primary endpoint

TIPRANKS
·
Yesterday

Market Chatter: Apollo Global in Talks to Buy J&J Orthopedics Unit for $20 Billion

MT Newswires Live
·
Yesterday

One State's Battle to Stop People from Taking Unapproved Weight-Loss Drugs

Dow Jones
·
Yesterday

Nanobiotix announces updated safety, efficacy data from JNJ-1900 study

TIPRANKS
·
Yesterday